This systematic review synthesized 61 dynamically tailored eHealth interventions for chronic disease management from 117 papers. Tailoring strategies varied in scope and complexity, with most targeting physical activity (87%) and nutrition (43%), while nearly…
Continue Reading
Artificial intelligence and wearable technology are increasingly used in healthcare and hold significant potential for improving the management of diabetes. Wearable devices enable continuous monitoring and real-time data collection, supporting AI-driven personalized interventions. This…
Continue Reading
What You Should Know:
– Carrot, a global fertility and family care platform announced a significant strategic partnership with ŌURA, the smart ring company, and Dexcom, the global leader in glucose biosensing. The collaboration introduces…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, Inc. today announced that its t:slim X2 insulin pump, featuring the advanced Control-IQ+ automated insulin delivery (AID) technology, is now available with the integration of Abbott’s FreeStyle…
Continue Reading
Acquisition Extends Glooko’s Diabetes Digital Health Platform into Hospitals, Creating a Comprehensive Inpatient-to-Outpatient Diabetes Management Connected Care Solution
Deal Underscores Glooko’s Commitment to Accelerating Growth and Innovation in Diabetes Care
Glooko, Inc., a leading provider of…
Continuous prediction of glucose levels and hypoglycemia events is critical for managing type 1 diabetes mellitus (T1DM) under intensive insulin therapy. Existing models focus on a single task, limiting their practicality and adaptability in…
Continue Reading
What You Should Know:
– Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System.
– The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight management….
Continue Reading
Mums-to be in England with type 1 diabetes will receive a pregnancy-specific ‘artificial pancreas’ from the NHS so they can effectively manage their blood glucose levels.
Around 2,000 women with type 1 diabetes become pregnant…
What You Should Know:
– Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization…
Continue Reading
Background: Self-monitoring of blood glucose (SMBG) is recommended in clinical practice guidelines, including those in China, as part of patient education, self-management, and empowerment. With technological advancements, telecommunication technologies are now used for telemonitoring…
Continue Reading
